EDIT Q2 2024 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$256M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$513,000-82.2% YoY

Gross Profit

-$907,000-176.8% margin

Operating Income

-$72M-14016.2% margin

Net Income

-$68M-13178.8% margin

EPS (Diluted)

$-0.82

QoQ Revenue Growth

-54.8%

Cash Flow

Operating Cash Flow

-$57M

Free Cash Flow

-$61M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$385M

Total Liabilities

$153M

Stockholders' Equity

$232M

Cash & Equivalents

$64M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$513,000	$3M	-82.2%
Gross Profit	-$907,000	-$27M	+96.6%
Operating Income	-$72M	-$44M	-63.1%
Net Income	-$68M	-$40M	-67.8%